Results 121 to 130 of about 6,767 (186)

Immune-mediated acute thrombocytopenia within 30 minutes of first obinutuzumab infusion. [PDF]

Blood Vessel Thromb Hemost
Al-Sayyad J, Lara-Martinez HR.
europepmc   +1 more source

Outcome and response to different management regimens in pediatric patients with immune thrombocytopenia (ITP). [PDF]

Ann Hematol
AbdelAziz RA, El-Sayed D, Ahmed FEZ, Komy MA.   +3 more
europepmc   +1 more source

Limitations of rituximab in treating primary immune thrombocytopenia and the therapeutic potentials of alternatives. [PDF]

Curr Opin Hematol
Pan L, Zhu J.
europepmc   +1 more source

Stratified assessment of platelets in sepsis: from dynamic counts to functional phenotypes. [PDF]

Front Immunol
Liu Y, Zou Y, Liu X, Li M.
europepmc   +1 more source

Efficacy and safety of hetrombopag, a novel thrombopoietin receptor agonist, in children and adolescents with immune thrombocytopenia: results from a randomized, multicenter, placebo-controlled phase 3 trial. [PDF]

J Hematol Oncol
Wu R, Gao J, Liu Y, Yu J, Hu S, Liang H, Jiang H, Zhai X, Zhou M, Hao W, Mei H, Li F, Chen Y, Liu W, Yan M, Li R, Xiong J, Zhu Z, Cheng X, Wang T.   +19 more
europepmc   +1 more source

The Role of IFN-γ-Mediated Immune Cell Crosstalk in the Pathogenesis of Aplastic Anemia. [PDF]

J Immunol Res
Tan S, Li Y, Chen Y, Sun W.
europepmc   +1 more source

Hetrombopag for thrombocytopenia induced by concurrent or sequential chemoradiotherapy in patients with solid tumors: a double-cohort trial. [PDF]

BMC Cancer
Cheng Y, Zhai C, Wang Q, Ai J, Wang Y, Liu Q, Cao F, Jiao W, Zhang X, Wang J.   +9 more
europepmc   +1 more source

B cell-driven refractory hemocytopenia in immune checkpoint inhibitor therapy: a report of two cases. [PDF]

Transl Lung Cancer Res
Li F, Wang C, Yao G, Zhang S, Hu Q, Ju Z, Liang W.   +6 more
europepmc   +1 more source

Comparative efficacy and safety of rhTPO, romiplostim, and eltrombopag in the treatment of pediatric primary immune thrombocytopenia: a systematic review and network meta-analysis. [PDF]

Front Immunol
Zhang X, Zhao Y, Yang M, Feng X.
europepmc   +1 more source

Optimization of thrombopoietin mimetic peptide fusion proteins with albumin-binding domain for enhanced bioactivity and extended half-life. [PDF]

Sci Rep
Ying J, Zheng Y, Xu X, Yang J, Hu A, Gao G.   +5 more
europepmc   +1 more source